Tyloxapol inhibits NF-kappa B and cytokine release, scavenges HOCl, and reduces viscosity of cystic fibrosis sputum

Published

Journal Article

Full Text

Duke Authors

Cited Authors

  • Ghio, AJ; Marshall, BC; Diaz, JL; Hasegawa, T; Samuelson, W; Povia, D; Kennedy, TP; Piantadosi, CA

Published Date

  • September 1996

Published In

Volume / Issue

  • 154 / 3

Start / End Page

  • 783 - 788

International Standard Serial Number (ISSN)

  • 1073-449X

Digital Object Identifier (DOI)

  • 10.1164/ajrccm.154.3.8810619